Drugs that contain Darunavir

1. Drug name - PREZISTA

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8518987 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Feb, 2024

(1 year, 4 months from now)

US7700645 JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor
Dec, 2026

(4 years from now)

CN1668623A JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

CN100475819C JANSSEN PRODS A Pseudo-Polymorphic Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591A1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP1567529A2 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2314591B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP3045460B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

EP2767539B1 JANSSEN PRODS Pseudopolymorphic Forms Of A Hiv Protease Inhibitor
May, 2023

(7 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8518987

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Aug, 2024

(1 year, 10 months from now)

US7700645

(Pediatric)

JANSSEN PRODS Pseudopolymorphic forms of a HIV protease inhibitor Jun, 2027

(4 years from now)

Treatment: NA

Dosage: SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
100MG/ML SUSPENSION;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.